O’Shea, John J.
Gadina, Massimo
Article History
First Online: 8 January 2019
Competing interests
: J.J.O’S. declares that he and the NIH hold a patent related to JAK inhibition in autoimmune disease and receive royalties from this patent. Both authors declare that they have a Collaborative Research and Development Agreement related to JAK inhibitors with Pfizer.